Author:
Ding Yanhua,Zhang Hong,Li Xiaojiao,Li Cuiyun,Chen Guiling,Chen Hong,Wu Min,Niu Junqi
Funder
National Major Scientific and Technological Special Project
National Natural Science Foundation of China
Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Reddy KR, Matelich MC, Ugarkar BG, et al. Pradefovir: a prodrug that targets adefovir to the liver for the treatment of hepatitis B. J Med Chem 2008;51(3):666–676
2. Marcellin P, Chang TT, Lim SG, Tong MJ, Sievert W, Shiffman ML, Jeffers L, Goodman Z, Wulfsohn MS, Xiong S, Fry J, Brosgart CL. Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. N Engl J Med 2003;348(9):808–816
3. HEPSERA® (Adefovir Dipivoxil Tablet 10 mg), full prescribing information for HEPSERA® Gilead
4. Price RG. The role of NAG (N-acetyl-β-d-glucosaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity. Clin Nephrol 1992;38:14–19
5. Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: summary of a workshop. Gastroenterology 2001;120:1828–1853
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献